The researchers will recruit and enroll Intermountain Healthcare patients into the study to create a biobank. The biobank — which will include genomic data from Precise and clinical outcomes data — will serve as a research resource for future precision medicine projects.
Researchers will complete tissue analyses at Intermountain Healthcare’s high-throughput sequencing facility in St. George, Utah.
“The multi-disciplinary nature and prospective design of Precise will be a challenge and require a tremendous amount of teamwork, but in the end, the pragmatic results will advance our knowledge regarding precision health and medicine initiatives,” said Tyler Barker, PhD, senior research scientist at Intermountain Healthcare and principle Investigator for the Precise study.
More articles on data analytics & precision medicine:
St. Jude launches public pediatric cancer genomics platform on the cloud
UCSF Health to apply predictive analytics to medical equipment maintenance
How DNA sequencing has improved public health since the 2000s
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.